Kilter Group’s Phibro Animal Health PAHC Stock Holding History

Kilter Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.7K	Buy	754 +390	+107%	+$16.5K	0.01%	257
2026 Q1	$20.1K	Buy	+364	New	+$17.3K	0.01%	233

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Kilter Group's PAHC Position: Q2 2026 in Review

Kilter Group increased its Phibro Animal Health (PAHC) stake by 107% in Q2 2026, buying an estimated $16.5K and bringing the position to 754 shares worth $23.7K. The position accounts for 0.01% of the portfolio, ranked #257.

Kilter Group first reported a position in PAHC in Q1 2026 and has held it in 2 quarters since. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Kilter Group held 754 shares of Phibro Animal Health worth $23.7K as of Q2 2026.
Kilter Group bought 390 Phibro Animal Health shares in Q2 2026, an estimated $16.5K.
Phibro Animal Health made up 0.01% of Kilter Group's portfolio in Q2 2026, its #257 holding.
Kilter Group first reported a position in Phibro Animal Health in Q1 2026 and has held it in 2 quarters since.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.